sr141716 has been researched along with pyrimidinones in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, SC; Butler, M; Carpino, PA; Day, R; Debartolo, DB; Dibrino, J; Dow, RL; Dutcher, D; Fichtner, MW; Gautreau, D; Griffith, DA; Hadcock, JR; Iredale, PA; Kelly-Sullivan, D; Lizano, JS; O'connor, RE; Rose, CR; Sakya, S; Sands, MA; Scott, DO; Ward, KM | 1 |
| Chaperon, F; Chen, YA; Commerford, SR; Dardik, B; Gerber, SP; Gromada, J; He, X; Hollenbeck, T; Jacobson, LH; Jaton, AL; Liu, H; McNamara, P; Nguyen-Tran, V; Schwartzkopf, C; Seidel, HM; Teixeira, S | 1 |
2 other study(ies) available for sr141716 and pyrimidinones
| Article | Year |
|---|---|
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.
Topics: Analgesics; Animals; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Feeding Behavior; Models, Biological; Piperidines; Pyrazoles; Pyrazolones; Pyrimidinones; Receptor, Cannabinoid, CB1; Rimonabant; Rodentia; Structure-Activity Relationship | 2006 |
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Inverse Agonism; Extinction, Psychological; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Motor Activity; Obesity; Piperidines; Pyrazoles; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Sleep, REM; Tissue Distribution | 2011 |